Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007010337) USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS FOR THE PREVENTION AND TREATMENT OF DISEASES OR HEALTH DISORDERS AND DISPENSING SYSTEM FOR SAID INHIBITORS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/010337 International Application No.: PCT/IB2006/001013
Publication Date: 25.01.2007 International Filing Date: 25.04.2006
IPC:
A61K 31/4985 (2006.01) ,A61P 3/04 (2006.01) ,A61P 3/10 (2006.01) ,A61P 9/04 (2006.01) ,A61F 6/08 (2006.01) ,A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
4985
Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
04
Anorexiants; Antiobesity agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
04
Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
F
FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
6
Contraceptive devices; Pessaries; Applicators therefor
06
for use by females
08
Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
PROXOMED MEDIZINTECHNIK GMBH [DE/DE]; Daimlerstrasse 6 63755 Alzenau, DE (AllExceptUS)
LEY, Thomas [DE/DE]; DE (UsOnly)
Inventors:
LEY, Thomas; DE
Priority Data:
10 2005 033 725.215.07.2005DE
Title (DE) VERWENDUNG VON PHOSPHODIESTERASE TYP 5-HEMMERN FÜR DIE PRÄVENTION UND BEHANDLUNG VON ADIPOSITAS, SOWIE ABGABESYSTEME FÜR DIESELBEN
(EN) USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS FOR THE PREVENTION AND TREATMENT OF DISEASES OR HEALTH DISORDERS AND DISPENSING SYSTEM FOR SAID INHIBITORS
(FR) UTILISATION D'INHIBITEURS DE PHOSPHODIESTERASE TYPE 5 POUR LA PREVENTION ET LE TRAITEMENT DE MALADIES OU DE TROUBLES, ET SYSTEMES D'ADMINISTRATION ASSOCIES
Abstract:
(DE) Die vorliegende Erfindung betrifft die Verwendung von Phosphodiesterase (PDE) Typ 5-Hemmern wie z.B. Sildenafil, Tadalafil oder Vardenafil, oder deren pharmazeutisch verträglichen Salzen zur Herstellung eines Medikaments für die Prävention und/oder Behandlung von Erkrankungen oder Gesundheitsstörungen, die mit einer übermäßigen Vermehrung des Fettgewebes im Körper verbunden sind. Insbesondere betrifft die Erfindung die Verwendung von Phosphodiesterase Typ 5-Hemmern zur Prävention und Behandlung der Adipositas . Des Weiteren stellt die Erfindung spezielle Abgabesysteme zur vaginalen und subkutanen Verabreichung von PDE5-Hemmern bereit .
(EN) The invention relates to the use of phosphodiesterase (PDE) type 5 inhibitors or their pharmaceutically compatible salts for producing a medicament for preventing and/or treating diseases or health disorders, which are associated with an excessive proliferation of adipose tissue in the body. In particular, the invention relates to the use of phosphodiesterase type 5 inhibitors for preventing and treating adiposity. In addition, the invention relates to special dispensing systems for the vaginal and sub-cutaneous administration of PDE5 inhibitors.
(FR) L'invention concerne l'utilisation d'inhibiteurs de phosphodiestérase (PDE) type 5 ou de leurs sels pharmaceutiquement compatibles, pour la production d'un médicament destiné à la prévention et/ou au traitement de maladies ou de troubles qui sont liés avec une multiplication excessive du tissu adipeux dans le corps humain. L'invention concerne en particulier l'utilisation d'inhibiteurs de phosphodiestérase type 5 pour la prévention et le traitement de l'adiposité. L'invention concerne en outre des systèmes d'administration particuliers, convenant pour l'administration vaginale et sous-cutanée d'inhibiteurs PDE5.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: German (DE)
Filing Language: German (DE)
Also published as:
EP1909793